Delivery Order SPE2DX15D3103-E261
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $99,693.00, is for the delivery of a variety of medical products and supplies to support TRICARE, the healthcare program for military personnel, veterans, and their families. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $99,933.60, is a Firm Fixed Price Delivery Order for the provision of various medical supplies and pharmaceutical products to support TRICARE, the healthcare program for active duty and retired military personnel, their families, and survivors. The contract is part of a larger...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $80,978.00 and is a firm fixed-price delivery order awarded on August 30, 2017, with a completion date of September 18, 2017. The contract is not designated as a set-aside and covers the provision of medical supplies and pharmaceuticals to support TRICARE, the...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $104,543.53, is a Firm Fixed Price Delivery Order for the provision of medical supplies to support TRICARE, the healthcare program for military personnel, veterans, and their families. The contract is not designated with a set-aside requirement, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Delivery Order, valued at $90,727.68, is for the provision of a range of pharmaceutical products and medical supplies to support TRICARE, the military healthcare program. The contract has a firm fixed-price pricing structure and does not have a set-aside designation, indicating open...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $78,364.50, is a Firm Fixed Price Delivery Order for the provision of TRICARE medical supplies to support the DLA's healthcare programs. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,070.48, is a firm fixed-price delivery order contract to provide a range of pharmaceutical products and medical supplies to support TRICARE, the military's healthcare program. The contract has no set-aside designation, indicating open competition. Amerisourcebergen also...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $96,802.88, is for the delivery of a variety of pharmaceutical products and medical supplies to support TRICARE, the healthcare program for U.S. military personnel, retirees, and their families. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $367,611.27, is for the provision of various medical supplies and pharmaceutical products to support TRICARE, the healthcare program for U.S. military personnel, veterans, and their families. As this is a delivery order under an...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $85,676.60, is a Firm Fixed Price Delivery Order for the provision of TRICARE medical supplies and pharmaceutical products to support military healthcare programs. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds two larger...
- SPE2DX15D3103Indefinite Delivery Contract
- SPE2DX15D3103-E261Delivery Order
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $78,030.46, is a firm fixed-price delivery order for the provision of a range of pharmaceutical products and medical supplies to support TRICARE, the healthcare program for U.S. military personnel, veterans, and their families. The contract is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to supply a comprehensive array of critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $78.0k | 12/29/16 |